To untangle the complex implications of the extracellular proteasome-OPN circuit in MS relapse/remission alternation, a pure in vitro/ex vivo experimental strategy would be insufficient, as it could limit the study to an observational level. The gene discussed is SPP1; the disease is myeloid sarcoma.